---
figid: PMC5406241__nihms827879f1
figlink: /pmc/articles/PMC5406241/figure/F1/
number: Fig 1
caption: Schematic illustrating our strategy to generate iPSCs resistant to IL-1-mediated
  signaling for tissue engineering applications. (A) Binding of IL-1 ligand to the
  IL1R1 receptor results in activation of a pro-inflammatory transcriptional program
  involving the transcription factors NF-κB, JNK, and MSK1. (B) Guide RNAs (gRNAs)
  target the genome editing nuclease Cas9 to two sites flanking exon 2 of IL1R1, which
  encodes the signal peptide sequence. (C) Cas9 induces DNA double-strand breaks (DSBs),
  which may be repaired via a DNA repair pathway known as non-homologous end joining.
  (D) This will lead to a subset of alleles with fully intact IL1R1, while others
  may have genomic disruptions at the IL1R1 locus, including excision of the signal
  peptide sequence, resulting in loss of signaling through IL1R1.
pmcid: PMC5406241
papertitle: CRISPR/Cas9 editing of induced pluripotent stem cells for engineering
  inflammation-resistant tissues.
reftext: Jonathan M. Brunger, et al. Arthritis Rheumatol. ;69(5):1111-1121.
pmc_ranked_result_index: '126870'
pathway_score: 0.9210976
filename: nihms827879f1.jpg
figtitle: Schematic illustrating our strategy to generate iPSCs resistant to IL-1-mediated
  signaling for tissue engineering applications
year: ''
organisms: Homo sapiens
ndex: 7e8f0650-df0e-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5406241__nihms827879f1.html
  '@type': Dataset
  description: Schematic illustrating our strategy to generate iPSCs resistant to
    IL-1-mediated signaling for tissue engineering applications. (A) Binding of IL-1
    ligand to the IL1R1 receptor results in activation of a pro-inflammatory transcriptional
    program involving the transcription factors NF-κB, JNK, and MSK1. (B) Guide RNAs
    (gRNAs) target the genome editing nuclease Cas9 to two sites flanking exon 2 of
    IL1R1, which encodes the signal peptide sequence. (C) Cas9 induces DNA double-strand
    breaks (DSBs), which may be repaired via a DNA repair pathway known as non-homologous
    end joining. (D) This will lead to a subset of alleles with fully intact IL1R1,
    while others may have genomic disruptions at the IL1R1 locus, including excision
    of the signal peptide sequence, resulting in loss of signaling through IL1R1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - MAPK11
  - IL1A
  - REL
  - MAPK13
  - MAPK12
  - IKBKG
  - MAPK10
  - NFKB2
  - RELA
  - MAPK9
  - UNK
  - MAPK8
  - MAPK14
  - MAPK3
  - RNASE9
  - MAP2K7
  - MAP2K4
  - IKBKB
  - TAB1
  - TAB2
  - RELB
  - NFKB1
  - TRADD
  - CHUK
  - NR2C2
  - ENG
  - MYD88
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: IL-1a
  symbol: IL-1A
  source: hgnc_alias_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: UNK
  symbol: UNK
  source: hgnc_symbol
  hgnc_symbol: UNK
  entrez: '85451'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAK1
  symbol: RAK1
  source: hgnc_alias_symbol
  hgnc_symbol: RNASE9
  entrez: '390443'
- word: MKK4/7
  symbol: MKK7
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K7
  entrez: '5609'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MKK4/7
  symbol: MKK4
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K4
  entrez: '6416'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: TAB1/2
  symbol: TAB1
  source: hgnc_symbol
  hgnc_symbol: TAB1
  entrez: '10454'
- word: TAB1/2
  symbol: TAB2
  source: hgnc_symbol
  hgnc_symbol: TAB2
  entrez: '23118'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: TRADD
  symbol: TRADD
  source: hgnc_symbol
  hgnc_symbol: TRADD
  entrez: '8717'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: TAK1
  symbol: TAK1
  source: hgnc_alias_symbol
  hgnc_symbol: NR2C2
  entrez: '7182'
- word: End
  symbol: END
  source: hgnc_alias_symbol
  hgnc_symbol: ENG
  entrez: '2022'
- word: MyD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
chemicals: []
diseases: []
---
